
Professor James Galloway
Professor of Rheumatology
- Deputy Head of the Centre for Rheumatic Diseases
- Senior Director for the GKT School of Medical Education
Biography
Professor James Galloway is a Professor of Rheumatology and a leading researcher in the field of inflammatory autoimmune diseases. His work focuses on leveraging big data and data science approaches to understand disease mechanisms, treatment responses, and healthcare delivery. He leads a dynamic research group at King’s College London, comprising NIHR clinical lecturers, PhD students, postdoctoral researchers, research nurses, and trials coordinators. His research spans disease epidemiology, predictive modeling for health outcomes, and pharmacovigilance. As the methodology lead for a UK national audit program, he plays a key role in evaluating and improving the quality of care for people with rheumatic diseases.
Graduating in medicine from the University of Bristol in 2001, Professor Galloway initially trained in internal medicine before specialising in rheumatology. He completed his PhD at the University of Manchester, working with the British Society for Rheumatology Biologics Register, the largest real-world dataset at the time for studying biologic therapies. His postdoctoral experience includes working in early-phase clinical trials and earning a clinical trials certification before establishing his research group at King’s College London in 2012. Clinically, he has a strong interest in inflammatory arthritis and rare diseases, running multidisciplinary subspecialty clinics for sarcoidosis, IgG4-related disease, and VEXAS syndrome.
Beyond research, Professor Galloway is deeply involved in medical education, recently appointed as Senior Director for the GKT School of Medical Education at King’s College London, one of the UK’s largest medical schools. He has chaired national and international guidelines—including the UK DMARD guideline and the European EULAR guideline on infection screening—and serves as Deputy Editor of Rheumatology, one of the leading journals in the field.
Teaching
- MBBS Chair of Assessment Board Programme Director
- PG Cert in Applied Research Methods Faculty Tutor
- KHP Research Design Course
Research

King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.

Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis than White patients, new research has shown.

King's College London announced winner of the Government's AI Fairness Innovation Challenge
A project led by Dr Zina Ibrahim, Senior Lecturer in Artificial Intelligence in Medicine at the Institute of Psychiatry, Psychology & Neuroscience, has won...

Developing Translational Research Capabilities in the School of Immunology & Microbial Sciences
Researchers from the School of Immunology & Microbial Sciences have been awarded funding through King's Health Partners Essentials for Translational Medical...

One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.

Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.

National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.

Events

Inaugural Lectures: Professors James Galloway & Anita Grigoriadis
Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research
Please note: this event has passed.
Research

King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.

Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis than White patients, new research has shown.

King's College London announced winner of the Government's AI Fairness Innovation Challenge
A project led by Dr Zina Ibrahim, Senior Lecturer in Artificial Intelligence in Medicine at the Institute of Psychiatry, Psychology & Neuroscience, has won...

Developing Translational Research Capabilities in the School of Immunology & Microbial Sciences
Researchers from the School of Immunology & Microbial Sciences have been awarded funding through King's Health Partners Essentials for Translational Medical...

One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.

Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.

National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.

Events

Inaugural Lectures: Professors James Galloway & Anita Grigoriadis
Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research
Please note: this event has passed.